Findlay D M, Omond S, Alford F P, Chisholm D J
J Clin Endocrinol Metab. 1979 Jan;48(1):13-6. doi: 10.1210/jcem-48-1-13.
Augmentation of insulin release after oral glucose by a gastrointestinal humoral mechanism is well accepted. The suggestion of a similar mechanism for suppression of glucagon release after oral glucose has not been previously tested. In this study, plasma glucagon levels have been estimated in five normal subjects after both oral and iv administration of glucose. A variable iv glucose infusion rate with frequent monitoring of blood glucose was used to match the hyperglycemia produced by the 50 g oral glucose and the iv glucose loads. Virtually complete suppression of plasma glucagon levels was seen in both cases (nadir of glucagon levels 16 +/- 6 pg/ml for oral glucose; 11.4 +/- 3 pg/ml for iv glucose). Thus, enteric humoral factors did not facilitate glucagon suppression after oral glucose ingestion in man. The vagus nerve is also involved in mediating the alpha-cell response to hypoglycemia and, thus, to examine whether hyperglycemia suppresses glucagon release through a vagal mechanism, iv atropine (15 microgram/kg) was given 20 min before administration of oral or iv glucose. Atropinization delayed the glucagon suppression after oral glucose, but this delay was probably related to delayed glucose absorption from the gut. With iv glucose, atropinization did not affect the degree of suppression of glucagon levels. It is concluded that alpha-cell suppression in response to hyperglycemia is not mediated via the vagus.
口服葡萄糖后通过胃肠体液机制增强胰岛素释放已被广泛接受。关于口服葡萄糖后抑制胰高血糖素释放存在类似机制的观点此前尚未得到验证。在本研究中,对5名正常受试者口服和静脉注射葡萄糖后的血浆胰高血糖素水平进行了评估。采用可变的静脉葡萄糖输注速率并频繁监测血糖,以匹配50克口服葡萄糖和静脉葡萄糖负荷所产生的高血糖状态。在两种情况下均观察到血浆胰高血糖素水平几乎完全被抑制(口服葡萄糖时胰高血糖素水平最低点为16±6皮克/毫升;静脉注射葡萄糖时为11.4±3皮克/毫升)。因此,在人体摄入口服葡萄糖后,肠内体液因素并未促进胰高血糖素的抑制。迷走神经也参与介导α细胞对低血糖的反应,因此,为了研究高血糖是否通过迷走神经机制抑制胰高血糖素释放,在口服或静脉注射葡萄糖前20分钟给予静脉注射阿托品(15微克/千克)。阿托品化延迟了口服葡萄糖后胰高血糖素的抑制,但这种延迟可能与肠道葡萄糖吸收延迟有关。对于静脉注射葡萄糖,阿托品化并未影响胰高血糖素水平的抑制程度。结论是,α细胞对高血糖的抑制不是通过迷走神经介导的。